SRRA - Sierra Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Major Holders
Insider Roster
Insider Transactions

Insider Transactions

Currency in USD
Insider Purchases Last 6 MonthsSharesTrans
Purchases00
SalesN/A0
Net Shares Purchased (Sold)00
Total Insider Shares Held2.86kN/A
% Net Shares Purchased (Sold)0.00%N/A
Net Institutional Purchases Prior Quarter to Latest QuarterShares
Net Shares Purchased (Sold)N/A
% Change in Institutional Shares HeldN/A

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDateShares

ORBIMED ADVISORS L L C
Beneficial Owner of more than 10% of a Class of Security

IndirectJan 29, 20201,477,320

AGGARWAL GAURAV
Director and Beneficial Owner of more than 10% of a Class of Security

IndirectJan 29, 20201,455,576

SINCLAIR ANDREW
Director

IndirectJan 29, 2020871,125

SINCLAIR ANDREW
Director

IndirectJan 29, 2020871,240

ASHIYA MONA PH.D.
Director and Beneficial Owner of more than 10% of a Class of Security

IndirectJan 29, 20201,477,320

RICHARDSON JOSHUA
Director and Beneficial Owner of more than 10% of a Class of Security

IndirectJan 29, 20201,477,320

VIVO OPPORTUNITY LLC
Beneficial Owner of more than 10% of a Class of Security

IndirectJan 29, 20201,856,118

CHAPMAN, WENDY ANNE
Officer

Sale at price 7.01 per share.Direct21,023Mar 22, 20163,000

CHAPMAN, WENDY ANNE
Officer

Conversion of Exercise of derivative security at price 0.97 per share.Direct2,907Mar 22, 20163,000

CHAPMAN, WENDY ANNE
Officer

Sale at price 7.06 per share.Direct21,180Feb 22, 20163,000

CHAPMAN, WENDY ANNE
Officer

Conversion of Exercise of derivative security at price 0.97 per share.Direct2,907Feb 22, 20163,000

CHAPMAN, WENDY ANNE
Officer

Sale at price 9.39 per share.Direct46,973Jan 22, 20165,000

CHAPMAN, WENDY ANNE
Officer

Conversion of Exercise of derivative security at price 0.97 per share.Direct4,845Jan 22, 20165,000

RODIGUEZA WENDI
Officer

Sale at price 9.59 - 10.32 per share.Direct29,573Jan 22, 20163,000

GLOVER NICHOLAS
Chief Executive Officer

Sale at price 10.04 per share.Direct50,223Jan 15, 20165,000

GLOVER NICHOLAS
Chief Executive Officer

Conversion of Exercise of derivative security at price 0.97 per share.Direct4,845Jan 15, 20165,000

LOVEJOY CHANDRA DENISE
Officer

Sale at price 11.06 - 11.93 per share.Direct236,833Jan 12, 201620,973

LOVEJOY CHANDRA DENISE
Officer

Conversion of Exercise of derivative security at price 0.97 per share.Direct7,317Jan 12, 20167,551

THOMPSON PETER A. M.D.
Director

Conversion of Exercise of derivative security at price 0.00 per share.Indirect0Jul 21, 20151,725,790